Metraipolis › archive › dc_71c10473f0cd

Development and Validation of LC-MS/MS Method for Nintedanib and BIBF 1202 Monitoring in Plasma of Patients with Progressive Pulmonary Fibrosis Associated… — Europe PMC PMID:41471068

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41471068
DOI
10.3390/pharmaceutics17121553
License (as archived)
solo-consultazione
Archived
2026-11-08T00:59:50.818Z
SHA-256 of the archived text
e71895ccd79774e50645baa87eec7bc3e07f91d9019382b7b533992f3502df13
Stable URL of this page
https://metraipolis.com/documento/dc_71c10473f0cd

How to cite

Development and Validation of LC-MS/MS Method for Nintedanib and BIBF 1202 Monitoring in Plasma of Patients with Progressive Pulmonary Fibrosis Associated… — Europe PMC PMID:41471068 — Europe PMC (en), https://europepmc.org/article/MED/41471068 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_71c10473f0cd (Metraipolis archive dc_71c10473f0cd, sha256 e71895ccd79774e50645baa87eec7bc3e07f91d9019382b7b533992f3502df13)
BibTeX
@misc{dc71c10473f0cd,
  title = {Development and Validation of LC-MS/MS Method for Nintedanib and BIBF 1202 Monitoring in Plasma of Patients with Progressive Pulmonary Fibrosis Associated… — Europe PMC PMID:41471068},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41471068},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_71c10473f0cd; sha256 e71895ccd79774e50645baa87eec7bc3e07f91d9019382b7b533992f3502df13},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41471068. Agents can read the archived copy with the MCP tool read_document.